Revenue
Sales from Product A 100 120 132 185 222
Sales from Product B 40 60 66 73 88
Total Sales 140 180 198 258 310
Operating Costs
Cost of the Raw Material 42 57 59 74 99
Selling,General & Administration Expenses 28 36 40 52 62
Provisions 21 27 30 39 47
Employee Renumeration & Benefits 14 18 20 26 31
Total Operating Costs 105 138 149 191 239
EBITDA 35 42 50 68 72
Other Income 15 18 20 28 33
Depreciation & Amortization 1 10 17 23 31
EBIT 49 51 52 72 74
Interest & Finance Charges 4 17 17 21 26
289
114
403
121
81
60
40
302
101
43
37
107
26
81
24
57
Balance Sheet
Fixed Assets
Gross Block 0 10 95 174 232 311
Less: Accumulated Depreciation 1 11 28 51 82
Net Block 9 85 146 181 229
Current Assets
Cash & Bank Balances 173 320 284 364 364
Short Term Marketable Investment - 5 2 6 8
Receivables 14 18 20 26 31
Inventories 5 8 12 16 19
Sundry Debtors 5 6 7 9 11
Loans & Advances - 12 13 17 20
Other Current Assets 9 17 24 32 42
Total Current Assets 206 386 361 469 495
1 1 1 1 1
FY 15 FY 16 FY 17 FY 18 FY 19 FY 20
372
119
253
78
50
417
12
40
24
14
26
52
585
966
200
100
300
12
10
15
223
261
561
405
200
-
205
405
1
Assumption
P/L Drivers
Revenue
Sales from Product A 20% 10% 40%
Sales from Product B 50% 10% 11%
Operating Costs
Cost of the Raw Material 30% 32% 30% 29%
Selling,General & Administration Expenses (SG&A) 20% 20% 20% 20%
Provisions 15% 15% 15% 15%
Employee Renumeration & Benefits 10% 10% 10% 10%
Other Income 9% 6% 7% 8%
Depreciation & Amortization 10% 10% 10% 10%
Interest & Finance Charges 8% 9% 9% 8%
Taxes 30%
BS Drivers
Fixed Assets
Capex as %age of revenue 7% 47% 40% 22%
Stores & Warehouses as %age of revenue 0% 11% 19% 21%
Investments -
Current Assets
Short Term Marketable Investments - (1) 2
Receivables in days 32 35 32
Inventories in days 13 18 20
Sundry Debtors in days 11 12 11
Other Current Assets 89% 41% 33%
9% 10% 8% 8% 9% 9% 9% Av
10% 10% 10% 10% 10% 10% 10% Av
9% 9% 9% 9% 9% 9% 9% Av
31 32 33 33 33 32 33 av
20% 30% 24% 23% 25% 24% 25% gr-av
20% 30% 24% 23% 25% 24% 25% gr-av
P&L Statement
Revenue
Sales from Product A 100 120 132 185 222
Sales from Product B 40 60 66 73 88
Total Sales 140 180 198 258 310
Operating Costs
Cost of the Raw Material 42 57 59 74 99
Selling,General & Administration Expense 28 36 40 52 62
Provisions 21 27 30 39 47
Employee Renumeration & Benefits 14 18 20 26 31
Total Operating Costs 105 138 149 191 239
EBITDA 35 42 50 68 72
Other Income 15 18 20 28 33
Depreciation & Amortization 1 10 17 23 31
EBIT 49 51 52 72 74
Interest & Finance Charges 4 17 17 21 26
57 38 53 73 94 126
Cash Flow Statement
Cash Schedule
Opening Balance
Net Change in Cash in the Year
Closing Balance 173
FY 15 FY 16 FY 17 FY 18 FY 19 FY 20
Valuation
Risk free rate 4%
Beta 0.90
Expected return from market 9%
Cost of equity 8.50%
Tax Rate 30%
Terminal Growth Rate 2%
No. of Equity Shares 1,000
All the figures are in $ Millions unless otherwise mentioned FY 10
Terminal Value
No. of Years
Present Value of cash flow
Fixed Assets
Gross Block 0 10 95 174 232 311
Less: Accumulated Depreciation 1 11 28 51 82
Net Block 9 85 146 181 229
Current Assets
Cash & Bank Balances 173 320 284 364 364
Short Term Marketable Investme - 5 2 6 8
Receivables 14 18 20 26 31
Inventories 5 8 12 16 19
Sundry Debtors 5 6 7 9 11
Loans & Advances - 12 13 17 20
Other Current Assets 9 17 24 32 42
Total Current Assets 206 386 361 469 495
1 1 1 1 1
FY 15 FY 16 FY 17 FY 18 FY 19 FY 20
417 - - - - -
12 19.71 31.48 46.40 50.50 58.02
40 50.27 61.73 77.88 96.86 122.05
24 26.14 39.09 43.81 59.26 68.68
14 17.08 22.00 27.17 34.54 42.54
26 25.85 25.85 25.85 25.85 25.85
52 68.84 91.14 119.07 154.90 201.16
585 207.90 271.30 340.18 421.90 518.31